Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

  • Showing results for nam yun cho. Your search for Nak Eun Cho retrieved no results.
1.

Helicobacter pylori Eradication Can Reverse the Methylation-Associated Regulation of miR-200a/b in Gastric Carcinogenesis.

Choi JM, Kim SG, Yang HJ, Lim JH, Cho NY, Kim WH, Kim JS, Jung HC.

Gut Liver. 2020 Jan 3. doi: 10.5009/gnl19299. [Epub ahead of print]

2.

Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.

Yoo SY, Park HE, Kim JH, Wen X, Jeong S, Cho NY, Gwon HG, Kim K, Lee HS, Jeong SY, Park KJ, Han SW, Kim TY, Bae JM, Kang GH.

Clin Cancer Res. 2020 Feb 15;26(4):870-881. doi: 10.1158/1078-0432.CCR-19-1159. Epub 2019 Nov 22.

PMID:
31757879
3.

Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.

Kim Y, Rhee YY, Wen X, Cho NY, Bae JM, Kim WH, Kang GH.

Gastric Cancer. 2019 Nov 5. doi: 10.1007/s10120-019-01025-8. [Epub ahead of print]

PMID:
31691036
4.

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma.

Yoo SY, Lee JA, Shin Y, Cho NY, Bae JM, Kang GH.

J Pathol Transl Med. 2019 Sep;53(5):289-297. doi: 10.4132/jptm.2019.06.07. Epub 2019 Jun 24.

5.

Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers.

Bae JM, Wen X, Kim TS, Kwak Y, Cho NY, Lee HS, Kang GH.

Cancer Res Treat. 2020 Jan;52(1):74-84. doi: 10.4143/crt.2019.062. Epub 2019 May 8.

6.

Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.

Shin YJ, Kim Y, Wen X, Cho NY, Lee S, Kim WH, Kang GH.

Clin Epigenetics. 2019 May 14;11(1):77. doi: 10.1186/s13148-019-0661-x.

7.

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

Oh HJ, Bae JM, Wen X, Jung S, Kim Y, Kim KJ, Cho NY, Kim JH, Han SW, Kim TY, Kang GH.

Br J Cancer. 2019 Apr;120(8):797-805. doi: 10.1038/s41416-019-0429-2. Epub 2019 Mar 21.

PMID:
30894685
8.

CpG Island Methylation in Sessile Serrated Adenoma/Polyp of the Colorectum: Implications for Differential Diagnosis of Molecularly High-Risk Lesions among Non-dysplastic Sessile Serrated Adenomas/Polyps.

Lee JA, Park HE, Yoo SY, Jeong S, Cho NY, Kang GH, Kim JH.

J Pathol Transl Med. 2019 Jul;53(4):225-235. doi: 10.4132/jptm.2019.03.12. Epub 2019 Mar 19.

9.

DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.

Kim Y, Lee K, Jeong S, Wen X, Cho NY, Kang GH.

Virchows Arch. 2019 Jul;475(1):49-58. doi: 10.1007/s00428-018-02511-7. Epub 2019 Jan 4.

PMID:
30610381
10.

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy.

Oh HJ, Kim JH, Bae JM, Kim HJ, Cho NY, Kang GH.

J Pathol Transl Med. 2019 Jan;53(1):40-49. doi: 10.4132/jptm.2018.11.29. Epub 2018 Dec 26.

11.

Multiplicity of Advanced T Category-Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma.

Park HE, Yoo S, Bae JM, Jeong S, Cho NY, Kang GH.

J Pathol Transl Med. 2018 Nov;52(6):386-395. doi: 10.4132/jptm.2018.10.02. Epub 2018 Nov 14.

12.

Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.

Kim Y, Wen X, Jeong S, Cho NY, Kim WH, Kang GH.

Gastric Cancer. 2019 Jan;22(1):37-47. doi: 10.1007/s10120-018-0852-8. Epub 2018 Jun 20.

PMID:
29926315
13.

The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.

Kim Y, Wen X, Bae JM, Kim JH, Cho NY, Kang GH.

Histopathology. 2018 Oct;73(4):663-671. doi: 10.1111/his.13674. Epub 2018 Jul 26.

PMID:
29906313
14.

Intratumoral immune cells expressing PD-1/PD-L1 and their prognostic implications in cancer: a meta-analysis.

Kim Y, Wen X, Cho NY, Kang GH.

Int J Biol Markers. 2018 May 1:1724600818770941. doi: 10.1177/1724600818770941. [Epub ahead of print]

PMID:
29779430
15.

Reply to 'Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system".

Bae JM, Kim JH, Kwak Y, Lee DW, Cha Y, Wen X, Lee TH, Cho NY, Jeong SY, Park KJ, Han SW, Lee HS, Kim TY, Kang GH.

Br J Cancer. 2018 Feb 6;118(3):e4. doi: 10.1038/bjc.2017.426. Epub 2018 Jan 2. No abstract available.

16.
17.

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma.

Jeong S, Lee K, Wen X, Kim Y, Cho NY, Jang JJ, Kang GH.

BMC Cancer. 2017 Aug 29;17(1):588. doi: 10.1186/s12885-017-3595-8.

18.

Deletion in HSP110 T17: correlation with wild-type HSP110 expression and prognostic significance in microsatellite-unstable advanced gastric cancers.

Kim KJ, Lee TH, Kim JH, Cho NY, Kim WH, Kang GH.

Hum Pathol. 2017 Sep;67:109-118. doi: 10.1016/j.humpath.2017.08.001. Epub 2017 Aug 12.

PMID:
28811251
19.

Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.

Park HE, Kim JH, Cho NY, Lee HS, Kang GH.

Virchows Arch. 2017 Sep;471(3):329-336. doi: 10.1007/s00428-017-2171-6. Epub 2017 Jun 8.

PMID:
28597080
20.

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer.

Oh HJ, Bae JM, Wen XY, Cho NY, Kim JH, Kang GH.

J Pathol Transl Med. 2017 May;51(3):306-313. doi: 10.4132/jptm.2017.01.19. Epub 2017 Apr 12.

Supplemental Content

Loading ...
Support Center